SERA Stock Analysis: Buy, Sell, or Hold?
SERA - Sera Prognostics, Inc. Class A Common Stock
$2.07
0.04 (1.97%)
▲
5d:
+4.02%
30d:
-1.9%
90d:
-28.62%
BUY
HIGH Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 06, 2026
Get Alerted When SERA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SERA shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: SERA shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: SERA is currently trading at $2.07, which is considered fair relative to its 30-day fair value range of $1.87 to $2.20.
Technical Outlook: Technically, SERA is in a strong downtrend. The price is approaching resistance at $2.11. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SERA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.00 (+141.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SERA is in a strong downtrend. The price is approaching resistance at $2.11. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SERA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.00 (+141.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$1.87 -
$2.20
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 141.5% below Wall St target ($5.00)
Fair Price Analysis
30-Day Fair Range
$1.87 -
$2.20
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$1.65
Resistance Level
$2.11
Current Trend
Strong Downtrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.09
Wall Street Target
$5.00
(+141.5%)
Revenue Growth (YoY)
-58.3%
Share & Embed Analysis
Last updated: April 02, 2026 4:23 AM ET
Data refreshes hourly during market hours. Next update: 5:23 AM
Data refreshes hourly during market hours. Next update: 5:23 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SERA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Benjamin Jackson
SELL
1027 shares
2026-03-11
John J Boniface
SELL
1517 shares
2026-03-11
Paul Kearney
SELL
1396 shares
2026-03-11
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 61 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$86 | 54 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 59 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$354 | 49 HOLD |
